Haemostatic Factors in Human Peripheral Afferent Lymph

Summary

Peripheral afferent lymph was obtained by cannulation of a collecting vessel in 17 healthy men (mean age 26 years). Lymph/plasma ratios of all vitamin K-dependent factors were lower than expected from molecular weight. Factor VII, factor IX and tissue factor pathway inhibitor (TFPI) lymph/plasma activity ratios were higher than antigen ratios. Activated factor VII (FVIIa) and TFPI-Xa complex concentrations were higher in lymph than plasma, and the raised FVIIa did not appear to be due to cannulation. The fibrinogen lymph/plasma activity (Clauss) ratio averaged about 20% of the antigen ratio. The result of an ELISA for D-dimer was higher in lymph than plasma, often more than five-fold. This high level in lymph was not explored but may indicate proteolysis of fibrinogen and fibrin with release of D-like and D-dimerlike fragments in interstitial fluid.

Keywords

Peripheral lymph - haemostatic factors - D-dimer

• References

• 1 Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol 1998; 60: 121-42.
• 2 Madara JL. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 1998; 60: 143-59.
• 3 Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, Malik AB. Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol 1987; 132: 111-7.
• 4 Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction protein. J Cell Biol 1996; 134: 1031-49.
• 5 Renkin EM. Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol 1985; 58: 315-25.
• 6 Predescu D, Horvat R, Predescu S, Palade GE. Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide. Proc Natl Acad Sci USA 1994; 91: 3014-8.
• 7 Schnitzer JE, Liu J, Oh P. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J. Biol Chem 1995; 270: 14399-404.
• 8 Predescu D, Predescu S, McQuistan T, Palade GE. Transcytosis of a. ₂acidic glycoprotein in the continuous microvascular endothelium. Proc Natl Acad Sci USA 1998; 95: 6175-80.
• 9 Siflinger-Birnboim A, Schnitzer J, Lum H, Blumenstock FA, Shen JC-P, Del Vecchio PJ, Malik AB. Lectin binding to gp60 decreases albumin binding and transport in pulmonary artery endothelial monolayers. J Cell Physiol 1991; 149: 575-84.
• 10 Garcia JGN, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW, Malik AB. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 1986; 128: 96-104.
• 11 Svensjo E, Arfors K-E, Raymond RM, Grega GJ. Morphological and physiological correlation of bradykinin-induced macromolecular efflux. Am J Physiol 1979; 236: H600-H606.
• 12 Rotrosen D, Gallin JI. Histamine type 1 receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers. J Cell Biol 1986; 103: 2379-87.
• 13 Haraldsson B, Rippe B. Orosomucoid as one of the serum components contributing to normal capillary permselectivity in rat skeletal muscle. Acta Physiol Scand 1987; 129: 127-35.
• 14 Taylor A, Gibson H. Concentrating ability of lymphatic vessels. Lymphology 1975; 08: 43-9.
• 15 Olszewski WL, Engeset A, Lukasiewicz H. Immunoglobulins, complement and lysozyme in leg lymph of normal men. Scand J Clin Lab Invest 1977; 37: 669-74.
• 16 Reichl D, Simons LA, Myant NB, Pflug J, Mills GL. Lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin Sci Mol Med 1973; 45: 313-29.
• 17 Olszewski WL. Collection and physiological measurements of peripheral lymph and interstitial fluid in man. Lymphology 1977; 10: 137-45.
• 18 Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. The lipids and apolipoproteins in prenodal leg lymph of fasted humans. Observations in normal subjects, familial lipoprotein lipase deficiency and familial lecithin cholesterol acyltransferase deficiency. Submitted for publication..
• 19 von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
• 20 Benson KWE, Borrett R, Biggs R. The specific assay of prothrombin using the Taipan snake venom. Br J Haematol 1971; 21: 219-26.
• 21 Brozovic M, Chakrabarti R, Stirling Y, Fenton S, North WRS, Meade TW. Factor V in an industrial population. Br J Haematol 1976; 33: 543-50.
• 22 Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu K K, Morrissey J H, Meade T W, Martin JC, Imeson J D, Cooper J A, Finch A. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48.
• 23 Morrissey J H, Macik B G, Neuenschwander P F, Comp P C. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
• 24 Denson K W E. The specific assay of Prower-Stuart factor and factor VII. Acta Haematol 1961; 25: 105-20.
• 25 Ford R P, Esnouf M P, Burgess A I, Sarphie A F. An enzyme linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma. J Immunoassay 1996; 17: 119-31.
• 26 Kitchin S, Malia RG. An assay for extrinsic pathway inhibitor. Med Lab Sci 1989; 46 (Suppl. 01) 40.
• 27 Dahlback B, Smith CA, Muller-Eberhard HJ. Visualization of human C4b -binding protein and its complexes with vitamin K-dependent protein S and complement C4b. Proc Natl Acad Sci USA 1983; 80: 3461-5.
• 28 DiScipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 1977; 16: 698-706.
• 29 Suomela H. Human coagulation factor IX Isolation and characterization. Eur J Biochem 1976; 71: 145-54.
• 30 Bradley WA, Gianturco SH. Vitamin K-dependent proteins bind to very low density lipoproteins. Semin Thromb Hemost 1988; 14: 253-7.
• 31 Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-4.
• 32 Mann KG, Nesheim ME, Tracy PB. Molecular weight of undegraded plasma factor V. Biochemistry 1981; 20: 28-33.
• 33 Nesheim ME, Foster WB, Hewick R, Mann KG. Characterization of factor V intermediates. J Biol Chem 1984; 259: 3187-96.
• 34 Marder VJ. Physicochemical studies of intermediate and final products of plasmin digestion of human fibrinogen. Thromb Diath Haemorrh (suppl) 1970; 39: 187-95.
• 35 Clemmensen I. Three new E-antigenic fibrinogen fractions found in a commercial plasmin preparation. Science Tools, LKB Instr J 1973; 20: 7-8.
• 36 Bach-Gansmo ET, Godal HC, Skjonsberg OH. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not by latex D-dimer test. Thromb Res 1998; 92: 125-34.
• 37 Kanade H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrinstabilizing factor (factor XIIIa). J Lab Clin Med 1975; 85: 574-97.
• 38 Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS. The covalent structure of factor XIIIa-crosslinked fibrinogen fibrils. J Struct Biol 1995; 115: 88-101.
• 39 Chung SI, Folk JE. Kinetic studies with transglutaminases. J Biol Chem 1972; 247: 2798-807.
• 40 Achyuthan KE, Rowland TC, Birckbichler PJ, Lee KN, Bishop PD, Achyuthan AM. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin and fibronectin. Mol Cell Biochem 1996; 162: 43-9.
• 41 Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein – associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-43.
• 42 Hubbard AR, Jennings CA. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins. Thromb Res 1987; 46: 527-37.
• 43 Hansen J-B, Huseby KR, Huseby N-E, Ezban M, Nordoy A. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factorinduced coagulaton in vitro. Thromb Res 1997; 85: 413-25.
• 44 Le DT, Borgs P, Toneff TW, Marlys HW, Rapaport SI. Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol 1998; 274: H769-H776.